Literature DB >> 1741204

Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection.

R G Faix1.   

Abstract

Severe infections caused by non-albicans Candida species are being increasingly reported among infants in neonatal intensive care units. To assess relative severity, mortality rates for C. albicans (CA) and C. parapsilosis (CP) infections in one neonatal intensive care unit from 1980 to 1990 were compared. Invasive candidiasis was defined as Candida recovery from a normally sterile body fluid or site with clinical signs of infection. Invasive candidiasis was diagnosed and systemic antifungal therapy initiated in 45 infants, 29 with CA and 16 with CP. No differences were found between CA and CP for birth weight, gestational age, age or weight at onset, presence of necrotizing enterocolitis, gastrointestinal or genitourinary anomalies, death (all causes), prior incidence or duration of antibiotics, parenteral nutrition, steroids or endotracheal intubation. Candida infection as the cause of death was more frequent with CA than CP (7 of 29 vs. 0 of 16; P = 0.034). Infants with CA were more likely to have antecedent thrush (P = 0.007) and perineal Candida dermatitis (P less than 0.02); those with CP were more likely to have vascular catheters at the time of positive culture (P less than 0.02). Though both pathogens occur in similar neonatal intensive care unit infants and can cause severe disease, CA appears more likely to result in death than CP.

Entities:  

Mesh:

Year:  1992        PMID: 1741204

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  18 in total

1.  Candida species differ in their interactions with immature human gastrointestinal epithelial cells.

Authors:  Christina Falgier; Sara Kegley; Heather Podgorski; Timothy Heisel; Kathleen Storey; Catherine M Bendel; Cheryl A Gale
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 2.  Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 3.  Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review.

Authors:  J Evdoridou; E Roilides; E Bibashi; G Kremenopoulos
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

4.  Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis.

Authors:  Y C Huang; T Y Lin; H S Leu; H L Peng; J H Wu; H Y Chang
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

Review 5.  Antifungal agents in neonatal systemic candidiasis.

Authors:  J N van den Anker; N M van Popele; P J Sauer
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

Review 6.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

Review 7.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants.

Authors:  Rodica Turcu; Maria Jevitz Patterson; Said Omar
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

Review 9.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

Review 10.  Antifungal agents in neonates: issues and recommendations.

Authors:  Benito Almirante; Dolors Rodríguez
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.